Subscribe
dna-istock-518143098-ralwel--2
ralwel / iStockphoto.com
26 April 2018Asia-Pacific

Merck KGaA secures CRISPR patent in China

China’s State Intellectual Property Office (SIPO) has granted Merck KGaA a patent covering its CRISPR technology used in a genomic-integration method for eukaryotic cells.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
Merck granted its first CRISPR patent in Australia
16 June 2017   Merck has been granted its first CRISPR technology patent by the Australian Patent Office.
Americas
GSK and Merck KGaA unite in €3.7bn immunotherapy deal
6 February 2019   UK headquartered GSK has made another move in the oncology space, signing a potential €3.7 billion immunotherapy deal with Germany-based Merck KGaA.
Asia
Merck KGaA secures CRISPR patents in Japan and Singapore
27 November 2019   The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Asia-Pacific
Merck granted its first CRISPR patent in Australia
16 June 2017   Merck has been granted its first CRISPR technology patent by the Australian Patent Office.
Americas
GSK and Merck KGaA unite in €3.7bn immunotherapy deal
6 February 2019   UK headquartered GSK has made another move in the oncology space, signing a potential €3.7 billion immunotherapy deal with Germany-based Merck KGaA.
Asia
Merck KGaA secures CRISPR patents in Japan and Singapore
27 November 2019   The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.

More on this story

Asia-Pacific
Merck granted its first CRISPR patent in Australia
16 June 2017   Merck has been granted its first CRISPR technology patent by the Australian Patent Office.
Americas
GSK and Merck KGaA unite in €3.7bn immunotherapy deal
6 February 2019   UK headquartered GSK has made another move in the oncology space, signing a potential €3.7 billion immunotherapy deal with Germany-based Merck KGaA.
Asia
Merck KGaA secures CRISPR patents in Japan and Singapore
27 November 2019   The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.

More features

Novartis shields eye-drop patent at European Patent Office
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages
Judge denies Intellia bid to throw out suit over $100m Regeneron pact